Related Experiment Video
Updated: Jul 30, 2025

12:35
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
28.2K
ALS-plus related clinical and genetic study from China
Cheng Chang1,2,3, Qianqian Zhao1, Pan Liu1
1Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China.
Summary
Amyotrophic lateral sclerosis (ALS) plus syndromes and cognitive impairment are common in China. ALS-plus patients differ clinically and genetically from pure ALS, with cognitive impairment linked to more ALS-plus symptoms.
Area of Science:
- Neurology
- Neurodegenerative Diseases
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder.
- Extramotor features, termed ALS-plus syndromes, and cognitive impairment are increasingly recognized in ALS patients.
- Clinical and genetic data on ALS-plus syndromes in China are limited.
Purpose of the Study:
- To investigate the frequency and characteristics of ALS-plus syndromes and cognitive impairment in a Chinese ALS cohort.
- To compare clinical and genetic features between ALS-plus and pure ALS groups.
- To explore the relationship between cognitive impairment and ALS-plus syndromes.
Main Methods:
- A cohort of 1015 ALS patients was classified based on extramotor symptoms and cognitive function.
- Clinical manifestations, demographic characteristics, and genetic data were analyzed.
- Genetic screening for rare damaging variants (RDVs) was performed on 847 patients.
Main Results:
- 16.75% of patients had ALS-plus syndrome; 49.5% had cognitive impairment.
- ALS-plus patients exhibited lower ALSFRS-R scores, longer diagnostic delays, and longer survival times compared to the pure ALS group.
- RDVs were less frequent in ALS-plus patients (P=0.042), and cognitive impairment was associated with more ALS-plus symptoms (P=0.001).
Conclusions:
- ALS-plus syndromes are prevalent in China and distinct from pure ALS in clinical and genetic aspects.
- Cognitive impairment in ALS is linked to a higher prevalence of ALS-plus symptoms.
- Findings support the concept of ALS as a spectrum of diseases with varied mechanisms.
Related Concept Videos
Genome-wide Association Studies-GWAS
13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.7K
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K

